|  Help  |  About  |  Contact Us

Publication : Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model.

First Author  Wang R Year  2011
Journal  Glia Volume  59
Issue  6 Pages  946-58
PubMed ID  21446050 Mgi Jnum  J:171207
Mgi Id  MGI:4948996 Doi  10.1002/glia.21167
Citation  Wang R, et al. (2011) Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model. Glia 59(6):946-58
abstractText  Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting predominantly motor neurons. Recent studies suggest that the disease progression of ALS is non-cell-autonomous, although the interaction between neurons and glial cells in different disease stages is not entirely clear. Here, we demonstrate that the interferon (IFN) signaling pathway is activated in human SOD1(G93A) transgenic mice, a rodent model of ALS. IFN-stimulated genes (ISGs) increased in the spinal cord of SOD1(G93A) mice at a presymptomatic age. In addition, the up-regulated ISGs, and most likely their transcriptional activators, were found specifically in astrocytes surrounding motor neurons, suggesting that IFN signaling in astrocytes was triggered by specific pathologic changes in motor neurons. Furthermore, induction of ISGs in cultured astrocytes was highly sensitive to IFN, especially Type I IFN. ISGs in astrocytes were activated specifically by endoplasmic reticulum stress-induced neurodegeneration in vitro, implicating a similar process in the presymptomatic stage of SOD1 mutant mice. Finally, reduction or deletion of IFNalpha receptor 1 inhibited IFN signaling and increased the life-span of SOD1(G93A) mice. Thus, the activation of IFN signaling pathways represents an early 'dialogue' between motor neurons and astrocytes in response to pathological changes in ALS. (c) 2011 Wiley-Liss, Inc.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Authors

6 Bio Entities

Trail: Publication

0 Expression